ABSTRACT
shown by Ene et al. 8 , who computationally analysed the haemodynamics in six abdominal aortic aneurysms under different assumptions, such as static/transient pressures, steady/transient flows and rigid/compliant walls. Vernhet et al. 7 and Morris et al. 2 showed a significant decrease in compliance when using small stents in small-calibre rabbit arteries and a SG device within an AAA perfusion model respectively, while Pihkala et al. 9 found that implanted stents in pig's aortas didn't affect aortic compliance or alter the pulse wave velocity (PWV). Also, in-vivo monitoring by intravascular ultrasound within coronary lesions shows a decrease in compliance post implantation of endovascular scaffolds. 10 Changes in arterial compliance triggers arterial dysfunction and pathophysiology, which have a key role in vascular biomechanics and homeostasis. 11 Vlachopoulos et al. 12 found that a 1 m/s increase in the PWV generates a 14% increased risk of cardiovascular events, cardiovascular mortality and all-cause mortality. Also, an increase of 1 SD in PWV is associated with a further increased risk of over 40%.
To date, little is known on the influence that commercially available devices have on the SG/arterial wall compliance for the treatment of AAAs. The hypothesis of this study is that SGs play a major role in altering the local arterial compliance after implantation. In this study we are investigating the mechanical behaviour of five commercially available endovascular devices: four SGs (Endurant II TM , Fortron TM , Zenith TM , Excluder TM ) and one multilayer flow modulator (MFM TM ) device, in order to discover if and how, the arterial compliance, is affected after implantation, by using an AAA perfusion model that, accurately, replicates the mechanical behaviour of the human aorta artery. The device/arterial wall compliance mismatch may be accounted for SG fixation problems such as Type I endoleaks and migration.
METHODS

Stent-Graft and MFM Devices
Four bifurcated SG devices and a Multilayer Flow Modulator TM (MFM TM ) device ( Figure   1B ) for the treatment of AAAs were dynamically tested within the AAA perfusion model.
The five tested devices were as follows:
 MFM TM (Cardiatis, Belgium), All SG devices ( Figure 1B ) have a thin walled graft covering the aneurysmal sac region, while the MFM TM has no graft covering along the stent structure. The MFM TM device is, also, bifurcated by having the lower tube half, stapled along the middle by the manufacturer, thus creating a bifurcation configuration with 2 tubular channels, in which two smaller MFM TM stents were deployed during implantation in the perfusion model as device limbs. Table 1 summarises the devices sizes according to IFU documentation. Based on the infrarenal internal/external neck sizes of the AAA, the clinicians sized the devices according to the manufacturer's indication for use (IFU) and not the maximum proximal diameter. The maximum proximal and distal diameters varied from (28 -30mm) and (14 -16mm), respectively. The AAA had an infrarenal neck angle of 57°, which falls within the IFU The different lengths resulted when selecting the devices used from the ones that we had access to. The devices were deployed inside the AAA perfusion model, as shown in Figure 2 (A & B), and neck outer diameters were measured at rest without any pressurization, as shown in Table 2 , in order to ensure that the experiment started at similar levels of neck dilatation. The measurements were focused on the proximal neck of the aneurysm without being influenced by the length of each device.
Circumferential force test rig setup
The chronic outward force is a measure of the force the stent exerts on the artery, as it tries to expand to its nominal diameter during vessel expansion. The radial resistive force is a measure of the force the stent exerts, as it resists circumferential compression by constriction of the artery. Both parameters depend on the state of compression. The terms chronic outward force and radial resistive force were coined by Duerig et al. 13 to better describe the circumferential forces of self-expanding stents.
Chronic outward and radial resistive circumferential forces were measured with the use of a high strength, low friction, 10mm wide and 0.2mm thickness, double strip material (DuPont™ Tyvek® paper with polyester / polyethylene laminated film), that was looped around the proximal end of the SG devices, and threaded through a narrow gap between two rollers, of the circumferential force test rig ( Figure 1A ), similar to the tests conducted by Duda et al. 14 One end of the strip was attached to a fixed base, while the other end was given by the following formula:
where Cd is the circumferential displacement, D is the maximum proximal diameter of the device.
Devices were preheated in an oven at 45°C for 10 min, to ensure full stent expansion before testing. The test started with the stent-grafts expanded to the maximum proximal diameter state. All devices were crimped to 80% of the initial diameter and then unloaded to the nominal outer diameter, forming a cycle as shown in Figure 3 .
Patient-specific AAA perfusion model fabrication
A patient-specific thin-walled flexible AAA perfusion model with intraluminal thrombus 
Flow simulator system
Blood was replicated with 56% deionised water and 44% glycerine (Univar Ltd., West The compliance (C) 21 of the non-stented and stented AAA perfusion models were calculated by the following formula.
Where, the pressure (P) and area (A) were based on the systole and diastole values of the cardiac cycle. The AAA perfusion model had a median compliance variation of 5. In order to compare and validate the results with other studies from the literature, the following derived parameters were calculated: pulsatile arterial energy loss (PAEL), pulse wave velocity (PWV) and wave reflection coefficient (Γ).
Pulsatile Arterial Energy Loss (PAEL)
The ∆P-∆D curve of the AAA perfusion model exhibits a hysteresis effect similar to the invivo measurements of Sonesson et al. 20 and Stefanadis et al. 22 This area within the aortic loop represents the pulsatile arterial energy loss 22 (PAEL). The calculated energy loss for the unstented AAA perfusion model, at the suprarenal location, was 3.5mmmmHg. This was within the descending aortic range of 3.16 to 14.10mmmmHg.
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Pulse wave velocity (PWV)
The PWV was measured by monitoring the pressures and diameters at the systolic and diastolic phases. This data was used to estimate the local PWV by applying Equation (3) 23 , as shown in Table 2 at the infrarenal location.
Where,
A is the diastolic cross-sectional area, ∆A is the difference between systolic and diastolic areas, ∆P is the difference between systolic and diastolic pressures,  is the density of the fluid.
Wave reflections
The wave reflections generated within the infrarenal aortic artery, before and after stenting, were computed by Equation 4 19 ( Table 2 ). This equation calculates the proportion of the pressure waveform being reflected, and is given by the reflection coefficient (Γ),
Where AU -cross-sectional area upstream from the proximal side, AS -cross-sectional area at the location of the proximal side, cU -PVW upstream from the proximal side, cS -PVW at the location of the proximal side.
RESULTS
Device deformation characteristics
The curves describing circumferential loading cycles and device deformation behaviour are shown in Figure 3 . The circumferential load was divided by the length of the stent in contact with the strip, and this is shown in Table 2 , which presents the magnitudes of the radial resistive and chronic outward forces expressed in N/cm, for all five SG devices at the influence the aortic compliance. Table 3 shows the infra to suprarenal device compliance index, which is the ratio of the mean infrarenal compliance divided by the mean suprarenal At the infrarenal region, the MFM™ did not significantly alter the unstented perfusion model PAEL median value of 2.3 mm·mmHg (p=0.903), while the other four devices increased the PAEL by 13 -44% (p<0.006), as shown in Table 2 .
Stented perfusion model pulse wave analysis
The PWV of the unstented infrarenal section had a median value of 10.6m/s, which was in agreement with the postoperative findings of Paraskevas et al. 24 , who clinically measured the mean aortic PWVs of 7.84  1.85m/s (preoperatively) and 10.08  1.57m/s (postoperatively)
within AAA cases. The PWV ranged from 10.9 m/s (MFM™, p=0.164) to 15.1m/s (Endurant II™, p<0.001) (see Table 2 ) for all devices tested. 
DISCUSSION
As far as the authors are aware, this is the first in-vitro study, which assessed the haemodynamic effects of a number of devices for the treatment of AAAs, within a patientspecific AAA perfusion model with the inclusion of ILT and correlated these effects with applied device fixation forces. Previous in-vivo studies have focused on the compliance mismatch of stents in small calibre arteries with one stent type stiffening the arterial wall while another has no effect.
7,9
The arterial wall is physiologically responsive to flow disturbances and material mismatch.
The compliance, relative pulsatility and pulsatile diameter are dramatically changed for implanted stents. 4, 10 It is unclear how stents affect the compliance of an artery as compliance varies from one type of stent to another. One stent type can cause the arterial wall to behave rigidly 7 , while another type may have no effect 10 . The compliance mismatch at the arterial/stent interface increases impedance to blood flow. This may result in decreased distal perfusion, increased pressure wave reflections and increased pulsatile mechanical stress at the interface between noncompliant stented vessels and native artery. 5, 25 For a complete study on compliance mismatch six SG types were tested. The radial force characterisation of SG devices within the proximal region is required to determine the fixation force that would be acting against the arterial wall. A low radial force can result in reduced stent fixation and eventual migration 26 , while a high radial force can lead to continued dilation leading to migration, Type I. 27 Previous studies applied point loads on stents to assess the radial force. 28 The problem with this method is that stents do not experience point loads in vivo. Another approach has externally compressed 29 stent/SG devices and this study found the stents/SGs to deform asymmetrically with hysteresis during the loading and unloading cycles. Johnston et al. 29 concluded that no usable relationship between pressure and area reduction could be determined due to this asymmetrical deformation. To apply axisymmetrical loading a strip can be wrapped around the proximal stent and pulled via a tensile testing machine deforming the stent circumferentially. 14 The advantage of this approach is the realistic response of the stent which provides quantifiable results. 29 The radial resistive force is a measure of the force the stent exerts, as it resists circumferential compression by constriction of the artery. 13 There was a significant amount of hysteresis associated with these circumferential loading and unloading curves, with the radial resistive force, considerably, larger than the chronic outward force. Similar findings were observed by Duda et al. 14 Table 2 . This resulted in a decreased compliance of 18 -23 % and 14 -25% for the suprarenal and infrarenal regions, respectively.
The other three devices (MFM™, Zenith™ and Fortron™) had a reduced compliance of 11 -14 % and 1 -7 % for the suprarenal and infrarenal regions, respectively. These differences in compliance between devices may be explained by the different elastic properties of the fabrics: woven polyester for Endurant II TM and ePTFE for Excluder TM . Tai et al. 30 , measured the compliance of Dacron (woven polyester) and ePTFE grafts, used for vascular reconstruction, and found that the Dacron has a higher compliance value (1.8 ± 1.2 per cent per mmHg×10 -2 ), compared to ePTFE (1.2 ± 0.3 per cent per mmHg×10 -2 ).
Referring to Table 3 , the vertical label (device names in bold) is read against the horizontal label (device names in italics). If the percentage difference values are both positive, it shows that the first data set (vertical label) was significantly greater than the second (horizontal label), and conversely two negative values indicate that the first data set was significantly lower than the second. For example, in the suprarenal region the vertical label (Endurant II™) was compared to the horizontal label (MFM™). This comparison showed a negative % difference (-22.8, -3.9; p=0.008), which means that MFM™ is more compliant than Endurant II™ at the suprarenal region. The three devices with suprarenal fixation (MFM™, Zenith™ and Fortron™) had no significant difference in compliance at the suprarenal (p>0.508) and infrarenal (p>0.172) regions. At the infrarenal region, the Excluder™ device, without proximal stent fixation, was less compliant than MFM™ (p=0.0013) and Fortron™ (p<0.001)
devices.
The hysteresis effect or the pulsatile energy losses within the infrarenal region was increased by the presence of the SG devices (Table 2 and Figure 5 ). The stiffest SG devices Compliance mismatch increases impendence to blood flow by increasing the PAEL within the arterial wall. 6 This increase in PAEL may result in decreased distal perfusion, increased pressure wave reflections and increased pulsatile mechanical stress at the interface between the noncompliant stented vessels and the native artery. 5, 6 The elasticity of the arterial wall is responsible for the existence of wave reflections. The propagating pressure or flow waveforms will be reflected, if the wave encounters any change in calibre along the arterial wall, such as, a variation in cross-sectional area or material properties as given by Equation
4
. 19 This variation in arterial calibre occurred after the insertion for all five devices with varying degrees of severity. Wave reflections lead to the early arrival of the pressure and flow waveforms reflected by the prosthetic junction. The early arrival of a reflected wave increases left ventricular load which affects both ventricular emptying and driving pressure for coronary perfusion 19, 31 , which eventually leads to low cardiac output, impaired coronary perfusion, heart failure, hypertension and shock. 19, 32 There was a maximum of 7% variation in the maximum proximal diameter between the five devices tested (Table 1) . Unfortunately, this variation was unavoidable since the preferred intended for use aortic diameters as documented by the manufacturers were within the aorta's infrarenal diameter range. This variation in maximum proximal diameter would further contribute to the differences in compliance found for all devices. Lower percentage radial pulsations would reduce the relative movement between the aortic wall and stent struts and may induce endothelialisation.
This study found differences between the devices performance in terms of the main parameters analysed, such as the compliance and radial forces. These differences arise mainly from the unique combination of material properties for the fabric and stent in each device (briefly described in Table 2 . This fact may suggest that similar stent designs may be suitable towards achieving the right balance for future devices, between compliant device behaviour and fixation radial force, which would prevent proximal migration without stiffening the arterial wall.
The reflection coefficient measurements that offer superiority to one device over another, may characterise the situations of highly angulated AAA necks, as it is the case in this study, which hasn't been reported yet. Therefore caution should be taken when interpreting these results.
Limitation
Two limitations to the circumferential loading test approach are the unknown: the friction effects and the local impingement of the stent against the roller and base. With our circumferential loaded test, the local impingement effects were eliminated by employing a combination of two rollers. The film used, DuPont™ Tyvek®, has a low coefficient of friction. The chronic outward force is a measure of the force the stent exerts on the artery, as it tries to expand to its nominal diameter during vessel expansion.
In this study we have assessed a homogenous and isotropic silicone wall, which is in contact with the device wall, thus creating a composite material. We assumed material homogeneity and isotropy, to allow the use of Equation (2) for calculating wall compliance because the fabric of the SGs was not stretched after deployment, and the devices struts strain within the ΔP was low. The relative movement between the stent struts and the aortic wall was not monitored. The PAEL parameter was assessed, only at the infrarenal neck, and not at the devices limbs, therefore it may not provide a strong relation with a potential cardiac risk.
Conclusion
The commercially available bifurcated aortic SG devices lower the arterial wall compliance at the stent/arterial wall interface after implantation. The Excluder™ device was found to be the most compliant in the surprarenal region, as this was the only tested device with no suprarenal fixation stent, while the MFM™ device performed better within the infrarenal region. From a clinical perspective, it is desired to select devices for treating AAAs, which produce the minimum arterial wall stiffening, in order to prevent long-term device related complications. Future studies should analyse, in a similar manner, a wider range of commercially available SG devices to identify those that would pertain for low or zero complications rate. 
